Stubborn inflation, louder Fed talk about interest rate hikes and higher energy costs linked to new geopolitical risks are pushing investors to rethink how they use dividend stocks. Reliable dividend payers with solid balance sheets can sometimes help offset inflation pressure, although they are not a cure all. This article looks at 3 stocks from an Inflation-Resistant Dividend Stocks screener that appear closely tied to the latest policy and inflation headlines. You will see how each stock might be helped or hurt by this backdrop so you can decide whether they deserve a closer look.

Abbott Laboratories (ABT)

Overview: Abbott Laboratories is a global healthcare company that sells diagnostics, medical devices, branded generic drugs and nutrition products, from lab tests and glucose monitors to cardiovascular devices and infant formula.

Operations: Abbott Laboratories generates most of its revenue from Medical Devices at about US$22.5b, followed by Diagnostic Products at about US$10.0b, Nutritional Products at about US$8.3b, Established Pharmaceuticals at about US$5.8b, with a small contribution from Other revenue.

Market Cap: US$186.9b

Abbott Laboratories may be of interest in an inflation and rate hike cycle because it combines a long record of dividend growth with a broad mix of essential healthcare products, which can give it pricing power when costs rise. The company is focusing on higher margin areas such as medical devices and cancer diagnostics, supported by the Exact Sciences tie up and the expanding Libre diabetes franchise. At the same time, it offers a 2.39% dividend yield and trades below some fair value estimates based on future cash flows. However, investors also need to consider its high debt load, recent margin pressure and exposure to tariffs and global healthcare policy. The key issue is how these strengths and pressure points balance out for long term income focused investors.

Abbott Laboratories sits at the crossroads of essential healthcare, dividend income and cost pressure, yet many investors still treat it as just another steady payer. Before you decide, review the 3 key rewards and 2 important warning signs that could reshape how you see its balance of pricing power, debt and policy exposure.

Consolidated Water (CWCO)

Overview: Consolidated Water is a water utility that produces drinking water from seawater, treats wastewater for reuse, and designs and operates water plants for governments and businesses across the Caribbean and the United States.

Operations: Consolidated Water generates most of its revenue from Services excluding Manufacturing at about US$47.5m, followed by Bulk at about US$33.8m, Retail at about US$32.8m and Manufacturing at about US$14.3m.

Market Cap: US$471.5m

Consolidated Water sits in a part of the market that often gets more attention when inflation is sticky and rate hikes are back on the table, because reliable water supply is essential and tends to keep demand more stable through cycles. The company has a mix of regulated utility style cash flows, a 1.89% dividend, growth projects like the Honolulu Kalaeloa desalination plant and a new 25 year Cayman license, and recent municipal orders that could support future revenue. At the same time, it relies heavily on a handful of Caribbean contracts, faces permitting risks and carries funding risk through external borrowing. For investors who want inflation resistant dividend potential with real project and regulatory risks attached, Consolidated Water may warrant closer consideration.

Consolidated Water’s mix of essential services and project wins can look like a simple inflation shield, yet the full story goes deeper. See how the analysis report for Consolidated Water reframes its contract reliance and funding risks.

Cranswick (LSE:CWK)

Overview: Cranswick is a UK food producer that supplies supermarkets, food service companies and other manufacturers with products ranging from fresh pork and chicken to cooked meats, pastries, houmous, antipasti, Mediterranean ingredients and even pet food.

Operations: Cranswick generates almost all of its revenue from Food at about £2.93b, with a smaller £47.6m contribution from Other, and most sales come from the United Kingdom at about £2.91b.

Market Cap: £2.91b

Cranswick stands out in an inflation and rate hike cycle because it sits in consumer staples, where shoppers still need to eat. It has been growing earnings faster than the wider UK food industry and reports improving profit margins. The company is investing heavily in automation, such as high speed sausage packing, and continues to pursue bolt on acquisitions, which together can support efficiency and product breadth. At the same time, the stock trades below one fair value estimate based on future cash flows while carrying a 2.07% dividend, although the P/E is slightly above the European food average and there has been meaningful insider selling. For investors who want income, growth and inflation resilience from a single UK stock, that mix deserves closer attention.

Cranswick’s mix of earnings growth, automation and acquisitions suggests the story is only half told. Get the fuller picture with the analyst forecasts for Cranswick and see what recent insider selling might really be signalling.

The three stocks covered here are only the starting point, since the full Inflation-Resistant Dividend Stocks screener surfaces 13 more companies with similarly compelling dividend track records, balance sheets and inflation aware business models. Use Simply Wall St to identify and analyze the specific catalysts, policy angles and income narratives that matter to you so you can focus on the highest conviction opportunities in this theme.

Take Control of Your Investment Journey

If Consolidated Water or any of these companies sound like a great opportunity, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value the ideal entry point. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Alternatives Before The Crowd Moves

Fresh ideas move first and move fast. Some stocks are building quiet momentum, others are dropping back under the radar for now. Do your homework before the crowd and consider acting based on your own research.

• Identify cash generative companies before their next breakout by reviewing the curated 56 high quality undervalued stocks that still trade at prices many investors may be overlooking.
• Track where real infrastructure demand could emerge next by scanning the focused 35 power grid technology and infrastructure stocks built around companies tied to grid upgrades and reliability.
• Evaluate opportunities ahead of potential automation trends by assessing the hand picked 34 robotics and automation stocks that connect robotics, productivity gains and long term adoption themes.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.